» Articles » PMID: 33762078

Risk Factors for Chronic Pulmonary Aspergillosis in Post-TB Patients

Overview
Specialty Pulmonary Medicine
Date 2021 Mar 25
PMID 33762078
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria.

Balogun O, Oladele R, Ajibola O, Davies A, Fashanu T, Nwosu A Microbiol Spectr. 2025; 13(3):e0153324.

PMID: 39912682 PMC: 11878091. DOI: 10.1128/spectrum.01533-24.


Identification of prognostic factors of chronic pulmonary aspergillosis: a retrospective cohort of 106 patients.

Zhu Z, Hao H, Tao R, Zhang Y J Thorac Dis. 2024; 16(11):7310-7319.

PMID: 39678851 PMC: 11635279. DOI: 10.21037/jtd-24-831.


Timing of recurrence after treatment of pulmonary TB.

Mithunage C, Denning D IJTLD Open. 2024; 1(10):456-465.

PMID: 39398436 PMC: 11467853. DOI: 10.5588/ijtldopen.24.0222.


Prevalence and predictors of Aspergillus seropositivity and chronic pulmonary aspergillosis in an urban tertiary hospital in Sierra Leone: A cross-sectional study.

Lakoh S, Kamara J, Orefuwa E, Sesay D, Jiba D, Adekanmbi O PLoS Negl Trop Dis. 2023; 17(7):e0011284.

PMID: 37459359 PMC: 10374077. DOI: 10.1371/journal.pntd.0011284.


Importance of -Specific Antibody Screening for Diagnosis of Chronic Pulmonary Aspergillosis after Tuberculosis Treatment: A Prospective Follow-Up Study in Ghana.

Ocansey B, Otoo B, Gbadamosi H, Afriyie-Mensah J, Opintan J, Kosmidis C J Fungi (Basel). 2023; 9(1).

PMID: 36675847 PMC: 9863599. DOI: 10.3390/jof9010026.